LUMOS PHARMA, INC. (LUMO) has 15 open-market insider trades by 6 insiders since 2021. The most active filer is Kevin M. Lalande, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Deerfield Private Design Fund III, L.P. | 10% Owner | — | 1 | $4.5M | 2021-01-08 |
| Kevin M. Lalande | Dir | — | 7 | $3.8M | 2024-12-12 |
| Joseph S. McCracken | Dir | — | 3 | $160K | 2024-12-12 |
| Richard J. Hawkins | CEO | — | 2 | $39K | 2024-12-12 |
| Aaron Schuchart | Chief Business Officer | — | 1 | $15K | 2024-12-12 |
| Thomas A. Raffin | Dir | — | 1 | $10K | 2024-12-12 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| John C. McKew | Chief Scientific Officer | Sell | $6K | 2024-08-06 |
| John C. McKew | Chief Scientific Officer | Sell | $6K | 2024-04-03 |
| John C. McKew | Chief Scientific Officer | Sell | $1K | 2024-02-06 |
| John C. McKew | Chief Scientific Officer | Sell | $11K | 2023-08-02 |
| John C. McKew | Chief Scientific Officer | Sell | $7K | 2023-04-04 |
| John C. McKew | Chief Scientific Officer | Sell | $2K |
Companies that share insiders with LUMO, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2023-02-02 |
| Joseph S. McCracken | Director | Buy | $20K | 2022-11-16 |
| Richard J. Hawkins | CEO | Buy | $21K | 2022-09-21 |
| Richard J. Hawkins | CEO | Buy | $18K | 2022-09-19 |
| Joseph S. McCracken | Director | Buy | $27K | 2022-08-25 |
| Thomas A. Raffin | Director | Buy | $10K | 2022-08-25 |
| John C. McKew | Chief Scientific Officer | Sell | $28K | 2022-08-02 |
| John C. McKew | Chief Scientific Officer | Sell | $1K | 2022-06-06 |
| John C. McKew | Chief Scientific Officer | Sell | $18K | 2022-04-05 |
| John C. McKew | Chief Scientific Officer | Sell | $25K | 2021-09-08 |